Search

Your search keyword '"Blankenship, Derek M."' showing total 12 results
Start Over Author "Blankenship, Derek M."
12 results on '"Blankenship, Derek M."'

5. The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis

Author

Blankley, Simon, primary, Graham, Christine M., additional, Turner, Jacob, additional, Berry, Matthew P. R., additional, Bloom, Chloe I., additional, Xu, Zhaohui, additional, Pascual, Virginia, additional, Banchereau, Jacques, additional, Chaussabel, Damien, additional, Breen, Ronan, additional, Santis, George, additional, Blankenship, Derek M., additional, Lipman, Marc, additional, and O’Garra, Anne, additional

Published
2016
Full Text
View/download PDF

6. A 380-gene meta-signature of active tuberculosis compared with healthy controls

Author

Blankley, Simon, primary, Graham, Christine M., additional, Levin, Joe, additional, Turner, Jacob, additional, Berry, Matthew P.R., additional, Bloom, Chloe I., additional, Xu, Zhaohui, additional, Pascual, Virgina, additional, Banchereau, Jacques, additional, Chaussabel, Damien, additional, Breen, Ronan, additional, Santis, George, additional, Blankenship, Derek M., additional, Lipman, Marc, additional, and O'Garra, Anne, additional

Published
2016
Full Text
View/download PDF

12. Prophylactic PEG placement in head and neck cancer: how many feeding tubes are unused (and unnecessary)?

Author

Madhoun MF, Blankenship MM, Blankenship DM, Krempl GA, and Tierney WM

Subjects
Adult, Aged, Cachexia prevention & control, Enteral Nutrition methods, Female, Gastroscopy adverse effects, Humans, Intubation, Gastrointestinal adverse effects, Male, Middle Aged, Retrospective Studies, Young Adult, Gastroscopy statistics & numerical data, Head and Neck Neoplasms surgery, Intubation, Gastrointestinal statistics & numerical data
Abstract

Aim: To determine the rate of use and non-use of prophylactic percutaneous endoscopic gastrostomy (PEG) tubes among patients with head and neck cancer (HNC) patients., Methods: All patients with HNC undergoing PEG between January 1, 2004 and June 30, 2006 were identified. Patients (or their next-of-kin) were surveyed by phone and all available medical records and cancer registry data were reviewed. Prophylactic PEG was defined as placement in the absence of dysphagia and prior to radiation or chemoradiation. Each patient with a prophylactic PEG was assessed for cancer diagnosis, type of therapy, PEG use, and complications related to PEG., Results: One hundred and three patients had PEG tubes placed for HNC. Thirty four patients (33%) could not be contacted for follow-up. Of the 23 (22.3%) patients with prophylactic PEG tubes, 11/23 (47.8%) either never used the PEG or used it for less than 2 wk. No association with PEG use vs non-use was observed for cancer diagnosis, stage, or specific cancer treatment. Non-use or limited use was observed in 3/6 (50%) treated with radiation alone vs 8/17 (47.1%) treated with chemoradiation (P = 1.0), and 3 of 10 (30%) treated with surgery vs 8 of 13 (62%) not treated with surgery (P = 0.21). Minor complications were reported in 5/23 (21.7%). One (4.3%) major complication was reported., Conclusion: There is a high rate of unnecessary PEG placement when done prophylactically in patients with head and neck cancer.

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results